Preliminary studies indicate conolidine may possibly inhibit certain ion channels, decreasing neuronal excitability and restricting suffering alerts. This system is especially appropriate in neuropathic suffering, the place irregular signaling triggers persistent soreness. In addition, conolidine appears to influence G protein-coupled receptor (GPC